Related Experiment Video
Updated: Jun 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Hyperlipidemia and primary prevention of stroke: does risk factor identification and reduction really work?
1Department of Neurology, New York Presbyterian Hospital, Weill Cornell, NY 10065, USA.
Insights
Hyperlipidemia increases stroke risk, but statins offer neuroprotection by lowering lipids. Despite guidelines and effective treatments like statins, achieving adequate lipid control remains challenging due to various barriers.
Area of Science:
- Neurology
- Cardiology
- Preventive Medicine
Background:
- Stroke is a leading cause of mortality and disability.
- Hyperlipidemia is a significant modifiable risk factor for stroke.
- Current guidelines exist for lipid screening and management.
Purpose of the Study:
- To review the role of hyperlipidemia in stroke.
- To discuss the efficacy of statins in stroke prevention.
- To identify barriers to optimal lipid management.
Main Methods:
- Literature review of studies on hyperlipidemia, stroke, and statin therapy.
- Analysis of lipid screening guidelines.
- Discussion of neuroprotective and pleiotropic effects of statins.
Main Results:
- Lowering low-density lipoprotein (LDL) and increasing high-density lipoprotein (HDL) levels correlate with reduced stroke risk.
- Statins effectively decrease lipid levels and offer neuroprotection.
- Significant barriers impede effective lipid control in the population.
Conclusions:
- Hyperlipidemia management is crucial for stroke prevention.
- Statins are effective therapeutic agents for reducing stroke risk.
- Addressing barriers to lipid management is essential for public health.
Abstract:
Stroke is one of the leading causes of death. Hyperlipidemia is a major risk factor for stroke. The United States Preventive Service Task Force defines lipid screening guidelines. Treatment options of hyperlipidemia include lifestyle modifications and medical management. Statins have been shown to decrease lipids and exert a pleiotropic effect on intracranial vasculature and inflammatory modulators, leading to neuroprotection. Lower low-density lipoprotein and higher high-density lipoprotein levels are associated with decreased risk of stroke. Despite screening guidelines and evidence of the efficacy of statins, there are numerous barriers to maintaining adequate control of lipids.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis I: Introduction